Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
American Journal of Medical Genetics
|
April 17, 2001
Non-replication of association between cathepsin D genotype and late onset Alzheimer disease
G Menzer, T Müller-Thomsen, W Meins, et al.
Gene Therapy
|
April 15, 2015
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine
O Riede, K Seifert, D Oswald, et al.
Neurogenetics
|
August 5, 2003
Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2
U Finckh, K van Hadeln, T Müller-Thomsen, et al.
Brain Research
|
May 2, 1997
Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements
C Hock, K Villringer, F Müller-Spahn, et al.
American Journal of Human Genetics
|
January 13, 2000
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes
U Finckh, T Müller-Thomsen, U Mann, et al.
Dementia and Geriatric Cognitive Disorders
|
July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease
C G Schipke, O Peters, I Heuser, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
High frequency of mutations in four different disease genes in early-onset dementia
U Finckh, T Müller-Thomsen, U Mann, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease
C Hock, A Maddalena, I Heuser, et al.
Molecular Psychiatry
|
July 10, 2003
Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease
M A Wollmer, J R Streffer, M Tsolaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 18, 2003
Saitohin gene is not associated with Alzheimer's disease
J R Streffer, A Papassotiropoulos, P Kurosinski, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
American Journal of Medical Genetics
|
April 17, 2001
Non-replication of association between cathepsin D genotype and late onset Alzheimer disease
G Menzer, T Müller-Thomsen, W Meins, et al.
Gene Therapy
|
April 15, 2015
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine
O Riede, K Seifert, D Oswald, et al.
Neurogenetics
|
August 5, 2003
Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2
U Finckh, K van Hadeln, T Müller-Thomsen, et al.
Brain Research
|
May 2, 1997
Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements
C Hock, K Villringer, F Müller-Spahn, et al.
American Journal of Human Genetics
|
January 13, 2000
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes
U Finckh, T Müller-Thomsen, U Mann, et al.
Dementia and Geriatric Cognitive Disorders
|
July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease
C G Schipke, O Peters, I Heuser, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
High frequency of mutations in four different disease genes in early-onset dementia
U Finckh, T Müller-Thomsen, U Mann, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease
C Hock, A Maddalena, I Heuser, et al.
Molecular Psychiatry
|
July 10, 2003
Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease
M A Wollmer, J R Streffer, M Tsolaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 18, 2003
Saitohin gene is not associated with Alzheimer's disease
J R Streffer, A Papassotiropoulos, P Kurosinski, et al.
Page
of 9